These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8229662)

  • 1. [Research and development of new oral cephems, cefixime and cefdinir].
    Sakane K; Kawabata K; Inamoto Y; Yamanaka H; Takaya T
    Yakugaku Zasshi; 1993 Sep; 113(9):605-26. PubMed ID: 8229662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bacteriological, pharmacokinetic and clinical studies of 5% and 10% granules of cefdinir in the pediatric field].
    Toyonaga Y; Hatakeyama K; Yamori K; Sakaguchi N; Nakano K; Yamazaki M; Sugita M; Hori M
    Jpn J Antibiot; 1992 Jan; 45(1):48-73. PubMed ID: 1495196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new oral cephem, cefdinir: its structure-activity relationships and biological profile].
    Sakane K; Inamoto Y; Takaya T
    Jpn J Antibiot; 1992 Aug; 45(8):909-25. PubMed ID: 1433897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibacterial activity of oral cephems against various clinically isolated strains and evaluation of efficacy based on the pharmacokinetics/pharmacodynamics theory].
    Nakamura T; Takahashi H
    Jpn J Antibiot; 2004 Dec; 57(6):465-74. PubMed ID: 15747584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antibacterial activity of FK482, a new orally active cephalosporin.
    Mine Y; Kamimura T; Watanabe Y; Tawara S; Matsumoto Y; Shibayama F; Kikuchi H; Takaya T; Kuwahara S
    J Antibiot (Tokyo); 1988 Dec; 41(12):1873-87. PubMed ID: 3264828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on FK482. II. Synthesis and structure-activity relationships of 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-substituted acetamido]-3-vinyl-3-cephem-4-carboxylic acid derivatives].
    Inamoto Y; Chiba T; Sakane K; Kamimura T; Takaya T
    Yakugaku Zasshi; 1990 Apr; 110(4):246-57. PubMed ID: 2376819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activity of novel 3-(2-propenyl)-cephalosporins. I.
    Kim WJ; Ko KY; Kim H; Oh J
    J Antibiot (Tokyo); 1991 Oct; 44(10):1073-82. PubMed ID: 1955389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on FK482 (Cefdinir). IV. Synthesis and structure-activity relationships of 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido]- 3-substituted cephalosporin derivatives].
    Inamoto Y; Sakane K; Kamimura T; Takaya T
    Yakugaku Zasshi; 1990 Dec; 110(12):908-15. PubMed ID: 2074536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibacterial activity and beta-lactamase stability of eleven oral cephalosporins].
    Bauernfeind A; Jungwirth R; Schweighart S; Theopold M
    Infection; 1990; 18 Suppl 3():S155-67. PubMed ID: 2079378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Structure-activity relationship of oral cephalosporins].
    Bingen E; Lambert-Zechovsky N
    Presse Med; 1989 Nov; 18(39):1923-7. PubMed ID: 2531868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo antibacterial activity and pharmacokinetics of SC-002 and its derivative, SC-004: new oral cephalosporins.
    Nagate T; Akashi T; Numata K; Sugita K; Kaneda Y; Matsuyama M; Saito H; Nozawa M; Onodera A; Hanada K; Kobori T; Fujita M; Yamamoto R; Hiyama T; Kondo K
    Chemotherapy; 2001; 47(3):157-69. PubMed ID: 11306784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelines.
    Gerlach EH; Jones RN; Allen SD; Koontz FP; Murray PR; Pfaller MA; Washington JA; Erwin ME
    Diagn Microbiol Infect Dis; 1992 Aug; 15(6):537-43. PubMed ID: 1424507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fundamental and clinical studies of cefixime granules in pediatrics].
    Sunakawa K; Saito N; Ishizuka Y; Iwata S; Kumagai N; Yokota T; Asaishi T; Kusano S; Sato Y; Kusumoto Y
    Jpn J Antibiot; 1986 Apr; 39(4):1035-54. PubMed ID: 3761536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity and stability to beta-lactamase of BMY-28271, a new oral cephalosporin ester.
    Matsui H; Hiraoka M; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1990 Apr; 34(4):555-61. PubMed ID: 2344162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of cefdinir (FK482) and ten other antibiotics against gram-positive and gram-negative bacteria isolated from adult and pediatric patients.
    Sultan T; Baltch AL; Smith RP; Ritz W
    Chemotherapy; 1994; 40(2):80-91. PubMed ID: 8131638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parameters characterizing the in vitro activity of cefixime, a new oral broad spectrum cephalosporin, against respiratory and urinary pathogens.
    Debbia EA; Marchese A; Pesce A; Saverino D; Schito GC
    J Chemother; 1992 Jun; 4(3):131-44. PubMed ID: 1517806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cefixime, the first oral third-generation cephalosporin].
    Roche G
    Presse Med; 1989 Oct; 18(32):1541-4. PubMed ID: 2530527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antibacterial activity of FK041, a new orally active cephalosporin.
    Watanabe Y; Hatano K; Matsumoto Y; Tawara S; Yamamoto H; Kawabata K; Takasugi H; Matsumoto F; Kuwahara S
    J Antibiot (Tokyo); 1999 Jul; 52(7):649-59. PubMed ID: 10513845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on cephalosporin antibiotics. IV. Synthesis, antibacterial activity and oral absorption of new 3-(2-substituted-vinylthio)-7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2- (carboxymethoxyimino)acetamido]cephalosporins.
    Yokoo C; Goi M; Onodera A; Fukushima H; Nagate T
    J Antibiot (Tokyo); 1991 Dec; 44(12):1422-31. PubMed ID: 1778793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on cephalosporin antibiotics. VI. Synthesis, antibacterial activity and oral efficacy in mice of new 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino)-acetamido]-3- (substituted alkylthio)cephalosporins.
    Yokoo C; Onodera A; Fukushima H; Numata K; Nagate T
    J Antibiot (Tokyo); 1992 Sep; 45(9):1533-9. PubMed ID: 1429240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.